导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.29% | 732/1050 |
| 近一周 | -2.37% | 775/1104 |
| 近一月 | -7.64% | 984/1103 |
| 近一季 | 3.87% | 166/1092 |
| 近半年 | -16.38% | 937/1070 |
| 近一年 | -16.92% | 846/1018 |
| 近两年 | 34.81% | 642/926 |
| 近三年 | -2.57% | 701/834 |
| 成立以来 | 176.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
8.78% 52/1070 |
-16.22% 1037/1101 |
- - |
- - |
| 2025 | 17.05% 721/1065 |
6.87% 295/1014 |
10.16% 97/1038 |
8.40% 873/1050 |
-8.28% 837/1065 |
| 2024 | -11.29% 789/1011 |
-15.17% 918/960 |
-6.93% 741/983 |
16.24% 164/991 |
-3.34% 558/1011 |
| 2023 | -14.99% 522/952 |
1.20% 560/880 |
-6.66% 621/895 |
-7.02% 431/915 |
-3.22% 341/952 |
| 2022 | -19.25% 302/867 |
-15.62% 288/773 |
-0.97% 717/806 |
-13.23% 482/845 |
11.38% 61/867 |
| 2021 | 2.80% 328/740 |
-2.38% 235/580 |
10.87% 332/659 |
-10.14% 512/704 |
5.69% 198/740 |
| 2020 | 77.96% 100/554 |
6.63% 59/419 |
33.47% 87/466 |
15.56% 137/517 |
8.20% 386/554 |
| 2019 | 59.06% 85/410 |
27.32% 526/1149 |
4.41% 58/1231 |
10.63% 102/390 |
8.16% 232/410 |
| 2018 | -17.77% 47/349 |
- - |
- - |
- - |
-11.92% 564/1080 |
| 2017 | 9.92% 133/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.36% 90/205 |
- - |
- - |
- - |
- - |
| 2015 | 47.52% 28/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 银河康乐股票A VS. 东吴新产业精选股票A(580008) |